Report Detail
Global (United States, European Union and China) Benfotiamine Market Research Report 2019-2025
- RnM3690053 |
- 22 August, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Chemical & Material
Benfotiamine is marketed as a dietary supplement in most of the developed world, and as a pharmaceutical drug in some countries for treating diabetic neuropathy
In 2019, the market size of Benfotiamine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Benfotiamine.
This report studies the global market size of Benfotiamine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Benfotiamine production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Klaire
Hamari
BioXera Pharma
Kaival Chemicals
Kimia Biosciences
AOR
Country Life
Neurohacker Collective
XY Mogen
Prayosha Health Care
Mascot
Pharmaffiliates
Hangzhou Eastbiopharm
Basil Pharmaceuticals
Ami Lifesciences
Market Segment by Product Type
Low Purity
High Purity
Market Segment by Application
Dietary Supplement
Diabetic Neuropathy
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Benfotiamine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Benfotiamine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Benfotiamine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Benfotiamine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Low Purity
- 1.3.3 High Purity
- 1.4 Market Segment by Application
- 1.4.1 Global Benfotiamine Market Share by Application (2019-2025)
- 1.4.2 Dietary Supplement
- 1.4.3 Diabetic Neuropathy
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Benfotiamine Production Value 2014-2025
- 2.1.2 Global Benfotiamine Production 2014-2025
- 2.1.3 Global Benfotiamine Capacity 2014-2025
- 2.1.4 Global Benfotiamine Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Benfotiamine Market Size CAGR of Key Regions
- 2.2.2 Global Benfotiamine Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Benfotiamine Capacity by Manufacturers
- 3.1.2 Global Benfotiamine Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Benfotiamine Revenue by Manufacturers (2014-2019)
- 3.2.2 Benfotiamine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Benfotiamine Market Concentration Ratio (CR5 and HHI)
- 3.3 Benfotiamine Price by Manufacturers
- 3.4 Key Manufacturers Benfotiamine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Benfotiamine Market
- 3.6 Key Manufacturers Benfotiamine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Low Purity Production and Production Value (2014-2019)
- 4.1.2 High Purity Production and Production Value (2014-2019)
- 4.2 Global Benfotiamine Production Market Share by Type
- 4.3 Global Benfotiamine Production Value Market Share by Type
- 4.4 Benfotiamine Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Benfotiamine Consumption by Application
6 Production by Regions
- 6.1 Global Benfotiamine Production (History Data) by Regions 2014-2019
- 6.2 Global Benfotiamine Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Benfotiamine Production Growth Rate 2014-2019
- 6.3.2 United States Benfotiamine Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Benfotiamine Import & Export
- 6.4 European Union
- 6.4.1 European Union Benfotiamine Production Growth Rate 2014-2019
- 6.4.2 European Union Benfotiamine Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Benfotiamine Import & Export
- 6.5 China
- 6.5.1 China Benfotiamine Production Growth Rate 2014-2019
- 6.5.2 China Benfotiamine Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Benfotiamine Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Benfotiamine Consumption by Regions
- 7.1 Global Benfotiamine Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Benfotiamine Consumption by Type
- 7.2.2 United States Benfotiamine Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Benfotiamine Consumption by Type
- 7.3.2 European Union Benfotiamine Consumption by Application
- 7.4 China
- 7.4.1 China Benfotiamine Consumption by Type
- 7.4.2 China Benfotiamine Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Benfotiamine Consumption by Type
- 7.5.2 Rest of World Benfotiamine Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Klaire
- 8.1.1 Klaire Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Benfotiamine
- 8.1.4 Benfotiamine Product Introduction
- 8.1.5 Klaire Recent Development
- 8.2 Hamari
- 8.2.1 Hamari Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Benfotiamine
- 8.2.4 Benfotiamine Product Introduction
- 8.2.5 Hamari Recent Development
- 8.3 BioXera Pharma
- 8.3.1 BioXera Pharma Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Benfotiamine
- 8.3.4 Benfotiamine Product Introduction
- 8.3.5 BioXera Pharma Recent Development
- 8.4 Kaival Chemicals
- 8.4.1 Kaival Chemicals Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Benfotiamine
- 8.4.4 Benfotiamine Product Introduction
- 8.4.5 Kaival Chemicals Recent Development
- 8.5 Kimia Biosciences
- 8.5.1 Kimia Biosciences Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Benfotiamine
- 8.5.4 Benfotiamine Product Introduction
- 8.5.5 Kimia Biosciences Recent Development
- 8.6 AOR
- 8.6.1 AOR Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Benfotiamine
- 8.6.4 Benfotiamine Product Introduction
- 8.6.5 AOR Recent Development
- 8.7 Country Life
- 8.7.1 Country Life Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Benfotiamine
- 8.7.4 Benfotiamine Product Introduction
- 8.7.5 Country Life Recent Development
- 8.8 Neurohacker Collective
- 8.8.1 Neurohacker Collective Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Benfotiamine
- 8.8.4 Benfotiamine Product Introduction
- 8.8.5 Neurohacker Collective Recent Development
- 8.9 XY Mogen
- 8.9.1 XY Mogen Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Benfotiamine
- 8.9.4 Benfotiamine Product Introduction
- 8.9.5 XY Mogen Recent Development
- 8.10 Prayosha Health Care
- 8.10.1 Prayosha Health Care Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Benfotiamine
- 8.10.4 Benfotiamine Product Introduction
- 8.10.5 Prayosha Health Care Recent Development
- 8.11 Mascot
- 8.12 Pharmaffiliates
- 8.13 Hangzhou Eastbiopharm
- 8.14 Basil Pharmaceuticals
- 8.15 Ami Lifesciences
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Benfotiamine Capacity, Production Forecast 2019-2025
- 9.1.2 Global Benfotiamine Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Benfotiamine Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Benfotiamine Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Benfotiamine Production Forecast by Type
- 9.7.2 Global Benfotiamine Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Benfotiamine Sales Channels
- 10.2.2 Benfotiamine Distributors
- 10.3 Benfotiamine Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Benfotiamine. Industry analysis & Market Report on Benfotiamine is a syndicated market report, published as Global (United States, European Union and China) Benfotiamine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Benfotiamine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
